• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为患有物质使用障碍的女性提供妇科检查和长效可逆避孕措施:一项前瞻性队列研究。

Facilitating gynecological examination and long acting reversible contraception for women with substance use disorder: a prospective cohort study.

作者信息

Finanger Trine, Skråstad Ragnhild Bergene, Appleton Catherine, Hagemann Cecilie Therese

机构信息

Clinic of Substance Use and Addiction Medicine, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.

出版信息

BMC Womens Health. 2025 May 24;25(1):252. doi: 10.1186/s12905-025-03794-0.

DOI:10.1186/s12905-025-03794-0
PMID:40413445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12102838/
Abstract

BACKGROUND

Women with substance use disorder (SUD) face a higher risk of sexual assault, abuse, cervical premalignant lesions, and unplanned pregnancy compared to the general female population. To meet the specific needs of this vulnerable group, we established a comprehensive gynecological service. The study aimed to describe the characteristics of women with SUD who accessed these services. Furthermore, we evaluated their cervical cytology and sexually transmitted infections (STIs) test results, preferred contraceptive methods, and the overall acceptability of the service.

METHODS

We enrolled 48 women undergoing outpatient or inpatient treatment for SUD in the South-Trøndelag region of Norway in the study. Each women received a comprehensive gynecological anamnesis, including a history of sexual assault, followed by a gynecological examination at the outpatient clinic of the Department of Obstetrics and Gynecology. The examination included ThinPrep Tests and microbiological swabs. They were also offered contraception options, with an emphasis on Long Acting Reversible Contraceptives (LARC), at no cost. Participants provided feedback on the service immediately after their consultation and again six months later.

RESULTS

Nearly two-thirds (63%) of the women with a mean age 31.8, reported a history of sexual assault. One in three (33%) had cervical cytology or human pappilomavirus (HPV) test results necessitating treatment or follow-up, though no cases of sexually transmitted infections were found. Two thirds (66%) of eligible women chose LARC as their contraceptive method. Among the 23 women reached for a follow-up phone call six months later, all expressed high level of satisfaction with the service and indicated they would recommend it to other women in similar situations.

CONCLUSIONS

An integrated, specialized gynecological service that provides cervical testing and contraceptive counselling can effectively reach women receiving outpatient or inpatient treatment for SUD, who typically fail to follow-up routine women's health screening programmes. If implemented, this approach has the potential to reduce unplanned pregnancies and improve early detection of cervical pathology in this vulnerable population.

摘要

背景

与一般女性人群相比,患有物质使用障碍(SUD)的女性面临更高的性侵犯、虐待、宫颈癌前病变和意外怀孕风险。为满足这一弱势群体的特殊需求,我们建立了一项全面的妇科服务。本研究旨在描述使用这些服务的患有SUD的女性的特征。此外,我们评估了她们的宫颈细胞学和性传播感染(STIs)检测结果、首选避孕方法以及该服务的总体可接受性。

方法

我们纳入了挪威南特伦德拉格地区48名因SUD接受门诊或住院治疗的女性参与研究。每位女性都接受了全面的妇科问诊,包括性侵犯史,随后在妇产科门诊进行了妇科检查。检查包括薄层液基细胞学检测(ThinPrep Tests)和微生物拭子检测。还免费为她们提供了避孕选择,重点是长效可逆避孕方法(LARC)。参与者在咨询后立即以及六个月后对该服务提供了反馈。

结果

平均年龄为31.8岁的女性中,近三分之二(63%)报告有性侵犯史。三分之一(33%)的女性宫颈细胞学或人乳头瘤病毒(HPV)检测结果需要治疗或随访,不过未发现性传播感染病例。三分之二(66%)符合条件的女性选择LARC作为她们的避孕方法。在六个月后通过电话随访联系到的23名女性中,所有人都对该服务表示高度满意,并表示会向其他处于类似情况的女性推荐。

结论

一项提供宫颈检测和避孕咨询的综合、专门的妇科服务能够有效地惠及因SUD接受门诊或住院治疗的女性,这些女性通常未能遵循常规的女性健康筛查计划。如果实施这种方法,有可能减少该弱势群体中的意外怀孕,并改善宫颈病变的早期检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e12/12102838/12099b8f1c30/12905_2025_3794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e12/12102838/12099b8f1c30/12905_2025_3794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e12/12102838/12099b8f1c30/12905_2025_3794_Fig1_HTML.jpg

相似文献

1
Facilitating gynecological examination and long acting reversible contraception for women with substance use disorder: a prospective cohort study.为患有物质使用障碍的女性提供妇科检查和长效可逆避孕措施:一项前瞻性队列研究。
BMC Womens Health. 2025 May 24;25(1):252. doi: 10.1186/s12905-025-03794-0.
2
Canadian Contraception Consensus (Part 2 of 4).加拿大避孕共识(共四部分,第二部分)
J Obstet Gynaecol Can. 2015 Nov;37(11):1033-9. doi: 10.1016/s1701-2163(16)30054-8.
3
Canadian Contraception Consensus (Part 1 of 4).加拿大避孕共识(共4部分,第1部分)
J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0.
4
An interactive website to aid young women's choice of contraception: feasibility and efficacy RCT.一个互动网站,帮助年轻女性选择避孕方法:可行性和有效性 RCT。
Health Technol Assess. 2020 Nov;24(56):1-44. doi: 10.3310/hta24560.
5
Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.采用短效避孕方法的女性对长效可逆避孕方法的接受度及意外妊娠情况:一项随机患者偏好试验
Am J Obstet Gynecol. 2017 Feb;216(2):101-109. doi: 10.1016/j.ajog.2016.08.033. Epub 2016 Sep 20.
6
Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.未寻求但尝试长效可逆避孕方法:一项关于持续使用、意外妊娠及满意度的24个月随机试验
Contraception. 2018 Jun;97(6):524-532. doi: 10.1016/j.contraception.2018.02.001. Epub 2018 Feb 19.
7
Integration of a contraception clinic into an opioid treatment setting to improve contraception knowledge, accessibility and uptake: a pilot study.将避孕诊所纳入阿片类药物治疗环境,以提高避孕知识、可及性和接受度:一项试点研究。
Aust N Z J Public Health. 2020 Oct;44(5):360-362. doi: 10.1111/1753-6405.13025. Epub 2020 Aug 31.
8
Improvement in contraceptive coverage and gynecological care of adult women with cystic fibrosis following the implementation of an on-site gynecological consultation.现场妇科咨询实施后,囊性纤维化成年女性的避孕措施覆盖率和妇科保健得到改善。
Contraception. 2020 Mar;101(3):183-188. doi: 10.1016/j.contraception.2019.10.014. Epub 2019 Nov 28.
9
Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge - A prospective cohort study in Finland.免费提供长效可逆避孕方法时选择的预测因素 - 芬兰的一项前瞻性队列研究。
Contraception. 2020 Jun;101(6):370-375. doi: 10.1016/j.contraception.2020.01.018. Epub 2020 Feb 13.
10
Use of Long-Acting Reversible Contraception Among Adolescent and Young Adult Women and Receipt of Sexually Transmitted Infection/Human Immunodeficiency Virus-Related Services.青少年和青年女性使用长效可逆避孕措施和接受性传播感染/人类免疫缺陷病毒相关服务的情况。
J Adolesc Health. 2018 Apr;62(4):417-423. doi: 10.1016/j.jadohealth.2017.10.017. Epub 2018 Feb 8.

本文引用的文献

1
Contraceptive uptake in postpartum people with and without opioid use disorder and opioid use with co-occurring substance use.有和没有阿片类物质使用障碍的产后人群以及同时存在物质使用情况时的阿片类物质使用与避孕药具的使用情况
Drug Alcohol Depend Rep. 2024 Jun 24;12:100248. doi: 10.1016/j.dadr.2024.100248. eCollection 2024 Sep.
2
Participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study.有当前或既往药物使用史的女性参与乳腺癌和宫颈癌筛查:一项调查研究。
BMC Public Health. 2023 Feb 16;23(1):352. doi: 10.1186/s12889-023-15236-3.
3
Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.
全球 202 个国家和地区的宫颈癌筛查规划和年龄别覆盖估计:综述和综合分析。
Lancet Glob Health. 2022 Aug;10(8):e1115-e1127. doi: 10.1016/S2214-109X(22)00241-8.
4
The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact?**译文**:COVID-19 大流行对性传播感染监测数据的影响:发病率下降还是假象?
BMC Public Health. 2021 Sep 7;21(1):1637. doi: 10.1186/s12889-021-11630-x.
5
Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.长效可逆避孕措施(LARCs)作为减少伤害的方法:一项探索有阿片类药物滥用史的女性观点的定性研究。
Harm Reduct J. 2021 Aug 4;18(1):83. doi: 10.1186/s12954-021-00532-1.
6
Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention.增加接受阿片类药物使用障碍治疗的女性获得计划生育服务的机会:一项试点随机试验,研究了一种由同伴主导的导航干预措施。
J Subst Abuse Treat. 2021 Jul;126:108318. doi: 10.1016/j.jsat.2021.108318. Epub 2021 Feb 4.
7
Cervical cancer among Swedish women with drug use disorders: A nationwide epidemiological study.瑞典药物滥用障碍女性的宫颈癌:一项全国性的流行病学研究。
Gynecol Oncol. 2021 Mar;160(3):742-747. doi: 10.1016/j.ygyno.2020.12.011. Epub 2020 Dec 31.
8
Collateral Damage: A Narrative Review on Epidemics of Substance Use Disorders and Their Relationships to Sexually Transmitted Infections in the United States.附带损害:美国物质使用障碍流行及其与性传播感染关系的叙事性综述。
Sex Transm Dis. 2021 Jul 1;48(7):466-473. doi: 10.1097/OLQ.0000000000001341.
9
Factors Affecting Contraception Access and Use in Patients With Opioid Use Disorder.影响阿片类药物使用障碍患者避孕措施获得和使用的因素。
J Clin Pharmacol. 2020 Dec;60 Suppl 2:S63-S73. doi: 10.1002/jcph.1772.
10
Polysubstance abuse among sexually abused in alcohol, drug, and gambling addiction treatment in Greenland: a cross sectional study.格陵兰岛性虐待酒精、药物和赌博成瘾治疗中的多种物质滥用:一项横断面研究。
Int J Circumpolar Health. 2021 Dec;80(1):1849909. doi: 10.1080/22423982.2020.1849909.